Introduction: The default mode network (DMN) is selectively vulnerable in brain aging. Little is known about the effect of multimorbidity as a whole onto the brain structural integrity. Objective: We aimed to investigate the association between multimorbidity and the structural integrity of DMN. Methods: We enrolled senior volunteers aged between 60 and 80 years in Hualien County during 2014–2018 and conducted in-person interview to collect information on chronic diseases. Fasting blood glucose and glycated hemoglobin (HbA1c) were tested. We assessed multimorbidity burden by the cumulative illness rating scale-geriatric (CIRS-G). MRI brain scans were standardized to measure the regional volume within the DMN. In a cross-sectional design, we employed stepwise regression models to evaluate the effects of age, sex, hyperglycemia, and multimorbidity on the DMN. Results: A total of 170 volunteers were enrolled with a mean age of 66.9 years, female preponderance (71%), an average mini-mental state examination score of 27.6, a mean HbA1c of 6.0, and a mean CIRS-G total score (TS) of 7.2. We found that older age was associated with reduced volumes in the hippocampus, left rostral anterior cingulate cortex, right posterior cingulate, right isthmus, precuneus, and right supramarginal. Higher levels of HbA1c and fasting glucose were associated with a reduced volume in the hippocampus only. A higher CIRS-G-TS was associated with reduced volumes in the left posterior cingulate cortex and right supramarginal gyrus; while a higher CIRS-G severity index was associated with a smaller right precuneus and right supramarginal. Conclusions: In the DMN, hippocampal volume shows vulnerability to aging and hyperglycemia, whereas the posterior cingulate, supramarginal, and precuneus cortices may be the key sites to reflect the total effects of multimorbidity.

1.
Biessels
GJ
,
Staekenborg
S
,
Brunner
E
,
Brayne
C
,
Scheltens
P
.
Risk of dementia in diabetes mellitus: a systematic review
.
Lancet Neurol
.
2006
;
5
:
64
74
. .
2.
Crane
PK
,
Walker
R
,
Hubbard
RA
,
Li
G
,
Nathan
DM
,
Zheng
H
,
Glucose levels and risk of dementia
.
N Engl J Med
.
2013
;
369
:
540
8
. .
3.
Moheet
A
,
Mangia
S
,
Seaquist
ER
.
Impact of diabetes on cognitive function and brain structure
.
Ann N Y Acad Sci
.
2015
;
1353
:
60
71
. .
4.
Ott
A
,
Stolk
RP
,
van Harskamp
F
,
Pols
HA
,
Hofman
A
,
Breteler
MM
.
Diabetes mellitus and the risk of dementia: the rotterdam study
.
Neurology
.
1999
;
53
:
1937
42
. .
5.
Rawlings
AM
,
Sharrett
AR
,
Mosley
TH
,
Ballew
SH
,
Deal
JA
,
Selvin
E
.
Glucose peaks and the risk of dementia and 20-year cognitive decline
.
Diabetes care
.
2017
;
40
:
879
86
.
6.
Reijmer
YD
,
van den Berg
E
,
de Bresser
J
,
Kessels
RP
,
Kappelle
LJ
,
Algra
A
,
Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors
.
Diabetes Metab Res Rev
.
2011
;
27
:
195
202
. .
7.
Spauwen
PJ
,
Köhler
S
,
Verhey
FR
,
Stehouwer
CD
,
van Boxtel
MP
.
Effects of type 2 diabetes on 12-year cognitive change: results from the maastricht aging study
.
Diabetes care
.
2013
;
36
:
1554
61
. .
8.
den Heijer
T
,
Vermeer
SE
,
van Dijk
EJ
,
Prins
ND
,
Koudstaal
PJ
,
Hofman
A
,
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI
.
Diabetologia
.
2003
;
46
:
1604
10
. .
9.
Hirabayashi
N
,
Hata
J
,
Ohara
T
,
Mukai
N
,
Nagata
M
,
Shibata
M
,
Association between diabetes and hippocampal atrophy in elderly Japanese: the Hisayama study
.
Diabetes care
.
2016
;
39
:
1543
9
. .
10.
Schneider
ALC
,
Selvin
E
,
Sharrett
AR
,
Griswold
M
,
Coresh
J
,
Jack
CR
 Jr
,
Diabetes, prediabetes, and brain volumes and subclinical cerebrovascular disease on MRI: the atherosclerosis risk in communities neurocognitive study (ARIC-NCS)
.
Diabetes care
.
2017
;
40
:
1514
21
. .
11.
Cherbuin
N
,
Sachdev
P
,
Anstey
KJ
.
Higher normal fasting plasma glucose is associated with hippocampal atrophy: the PATH study
.
Neurology
.
2012
;
79
:
1019
26
. .
12.
Samaras
K
,
Lutgers
HL
,
Kochan
NA
,
Crawford
JD
,
Campbell
LV
,
Wen
W
,
The impact of glucose disorders on cognition and brain volumes in the elderly: the sydney memory and ageing study
.
Age
.
2014
;
36
:
977
93
. .
13.
Weinstein
G
,
Maillard
P
,
Himali
JJ
,
Beiser
AS
,
Au
R
,
Wolf
PA
,
Glucose indices are associated with cognitive and structural brain measures in young adults
.
Neurology
.
2015
;
84
:
2329
37
. .
14.
Zhang
T
,
Shaw
M
,
Humphries
J
,
Sachdev
P
,
Anstey
KJ
,
Cherbuin
N
.
Higher fasting plasma glucose is associated with striatal and hippocampal shape differences: the 2sweet project
.
BMJ Open Diabetes Res Care
.
2016
;
4
:
e000175
. .
15.
Barnett
K
,
Mercer
SW
,
Norbury
M
,
Watt
G
,
Wyke
S
,
Guthrie
B
.
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
.
Lancet
.
2012
;
380
:
37
43
. .
16.
Marengoni
A
,
Angleman
S
,
Melis
R
,
Mangialasche
F
,
Karp
A
,
Garmen
A
,
Aging with multimorbidity: a systematic review of the literature
.
Ageing Res Rev
.
2011
;
10
:
430
9
. .
17.
Vassilaki
M
,
Aakre
JA
,
Cha
RH
,
Kremers
WK
,
St Sauver
JL
,
Mielke
MM
,
Multimorbidity and risk of mild cognitive impairment
.
J Am Geriatr Soc
.
2015
;
63
:
1783
90
. .
18.
Vassilaki
M
,
Aakre
JA
,
Mielke
MM
,
Geda
YE
,
Kremers
WK
,
Alhurani
RE
,
Multimorbidity and neuroimaging biomarkers among cognitively normal persons
.
Neurology
.
2016
;
86
:
2077
84
. .
19.
Yancik
R
,
Ershler
W
,
Satariano
W
,
Hazzard
W
,
Cohen
HJ
,
Ferrucci
L
.
Report of the national institute on aging task force on comorbidity
.
J Gerontol A Biol Sci Med Sci
.
2007
;
62
:
275
80
. .
20.
Mendes
A
,
Tezenas du Montcel
S
,
Levy
M
,
Bertrand
A
,
Habert
MO
,
Bertin
H
,
Multimorbidity is associated with preclinical Alzheimer’s disease neuroimaging biomarkers
.
Dement Geriatr Cogn Disord
.
2018
;
45
:
272
81
. .
21.
Abete
P
,
Della-Morte
D
,
Gargiulo
G
,
Basile
C
,
Langellotto
A
,
Galizia
G
,
Cognitive impairment and cardiovascular diseases in the elderly. A heart-brain continuum hypothesis
.
Ageing Res Rev
.
2014
;
18
:
41
52
. .
22.
Fabbri
E
,
An
Y
,
Zoli
M
,
Tanaka
T
,
Simonsick
EM
,
Kitner-Triolo
MH
,
Association between accelerated multimorbidity and age-related cognitive decline in older baltimore longitudinal study of aging participants without dementia
.
J Am Geriatr Soc
.
2016
;
64
:
965
72
. .
23.
Kuo
SC
,
Lai
SW
,
Hung
HC
,
Muo
CH
,
Hung
SC
,
Liu
LL
,
Association between comorbidities and dementia in diabetes mellitus patients: population-based retrospective cohort study
.
J Diabetes Complicat
.
2015
;
29
:
1071
6
. .
24.
Solomon
A
,
Dobranici
L
,
Kåreholt
I
,
Tudose
C
,
Lăzărescu
M
.
Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia
.
Int J Geriatr Psychiatry
.
2011
;
26
:
1244
51
. .
25.
Buckner
RL
,
Andrews-Hanna
JR
,
Schacter
DL
.
The brain’s default network: anatomy, function, and relevance to disease
.
Ann N Y Acad Sci
.
2008
;
1124
:
1
38
. .
26.
Fransson
P
,
Marrelec
G
.
The precuneus/posterior cingulate cortex plays a pivotal role in the default mode network: evidence from a partial correlation network analysis
.
Neuroimage
.
2008
;
42
:
1178
84
. .
27.
Raichle
ME
,
MacLeod
AM
,
Snyder
AZ
,
Powers
WJ
,
Gusnard
DA
,
Shulman
GL
.
A default mode of brain function
.
Proc Natl Acad Sci U S A
.
2001
;
98
:
676
82
. .
28.
Utevsky
AV
,
Smith
DV
,
Huettel
SA
.
Precuneus is a functional core of the default-mode network
.
J Neurosci
.
2014
;
34
:
932
40
. .
29.
Bailly
M
,
Destrieux
C
,
Hommet
C
,
Mondon
K
,
Cottier
JP
,
Beaufils
E
,
Precuneus and Cingulate cortex atrophy and hypometabolism in patients with alzheimer’s disease and mild cognitive impairment: MRI and (18)F-FDG PET quantitative analysis using freeSurfer
.
Biomed Res Int
.
2015
;
2015
:
583931
. .
30.
Barnes
J
,
Godbolt
AK
,
Frost
C
,
Boyes
RG
,
Jones
BF
,
Scahill
RI
,
Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD
.
Neurobiol Aging
.
2007
;
28
:
20
8
. .
31.
De Santi
S
,
de Leon
MJ
,
Rusinek
H
,
Convit
A
,
Tarshish
CY
,
Roche
A
,
Hippocampal formation glucose metabolism and volume losses in MCI and AD
.
Neurobiol Aging
.
2001
;
22
:
529
39
. .
32.
Fjell
AM
,
Westlye
LT
,
Amlien
I
,
Espeseth
T
,
Reinvang
I
,
Raz
N
,
High consistency of regional cortical thinning in aging across multiple samples
.
Cereb Cortex
.
2009
;
19
:
2001
12
. .
33.
Shima
K
,
Matsunari
I
,
Samuraki
M
,
Chen
WP
,
Yanase
D
,
Noguchi-Shinohara
M
,
Posterior cingulate atrophy and metabolic decline in early stage Alzheimer’s disease
.
Neurobiol Aging
.
2012
;
33
:
2006
17
. .
34.
Musen
G
,
Jacobson
AM
,
Bolo
NR
,
Simonson
DC
,
Shenton
ME
,
McCartney
RL
,
Resting-state brain functional connectivity is altered in type 2 diabetes
.
Diabetes
.
2012
;
61
:
2375
9
. .
35.
Sperling
RA
,
Laviolette
PS
,
O’Keefe
K
,
O’Brien
J
,
Rentz
DM
,
Pihlajamaki
M
,
Amyloid deposition is associated with impaired default network function in older persons without dementia
.
Neuron
.
2009
;
63
:
178
88
. .
36.
Lo
RY
,
Lo
YC
,
Chen
SC
,
Li
YY
,
Yang
YL
,
Chang
YL
,
Vascular burden and brain aging in a senior volunteer cohort: a pilot study
.
Ci Ji Yi Xue Za Zhi
.
2017
;
29
:
91
7
. .
37.
Goodman
RA
,
Posner
SF
,
Huang
ES
,
Parekh
AK
,
Koh
HK
.
Defining and measuring chronic conditions: imperatives for research, policy, program, and practice
.
Prev Chronic Dis
.
2013
;
10
:
E66
. .
38.
Miller
MD
,
Paradis
CF
,
Houck
PR
,
Mazumdar
S
,
Stack
JA
,
Rifai
AH
,
Rating chronic medical illness burden in geropsychiatric practice and research: application of the cumulative illness rating scale
.
Psychiatry Res
.
1992
;
41
:
237
48
. .
39.
Hudon
C
,
Fortin
M
,
Vanasse
A
.
Cumulative illness rating scale was a reliable and valid index in a family practice context
.
J Clin Epidemiol
.
2005
;
58
:
603
8
. .
40.
Mowinckel
AM
,
Vidal-Piñeiro
D
.
Visualisation of brain statistics with R-packages ggseg and ggseg3d
. arXiv preprint arXiv:191208200 2019.
41.
Benjamini
Y
,
Hochberg
Y
.
Controlling the false discovery rate: a practical and powerful approach to multiple testing
.
J R Stat Soc
.
1995
;
57
(
1
):
289
300
. .
42.
Ferreira
GD
,
Simões
JA
,
Senaratna
C
,
Pati
S
,
Timm
PF
,
Batista
SR
,
Physiological markers and multimorbidity: a systematic review
.
J Comorb
.
2018
;
8
:
2235042x18806986
. .
43.
Schottker
B
,
Saum
KU
,
Jansen
EH
,
Holleczek
B
,
Brenner
H
.
Associations of metabolic, inflammatory and oxidative stress markers with total morbidity and multi-morbidity in a large cohort of older German adults
.
Age and ageing
.
2016
;
45
:
127
35
.
44.
Leech
R
,
Sharp
DJ
.
The role of the posterior cingulate cortex in cognition and disease
.
Brain
.
2014
;
137
:
12
32
. .
45.
McCarrey
AC
,
Pacheco
J
,
Carlson
OD
,
Egan
JM
,
Thambisetty
M
,
An
Y
,
Interleukin-6 is linked to longitudinal rates of cortical thinning in aging
.
Transl Neurosci
.
2014
;
5
:
1
7
. .
46.
Raichle
ME
.
The brain’s default mode network
.
Annu Rev Neurosci
.
2015
;
38
:
433
47
. .
47.
Buckner
RL
,
Snyder
AZ
,
Shannon
BJ
,
LaRossa
G
,
Sachs
R
,
Fotenos
AF
,
Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory
.
J Neurosci
.
2005
;
25
:
7709
17
. .
48.
Park
JH
,
Hong
JH
,
Lee
SW
,
Ji
HD
,
Jung
JA
,
Yoon
KW
,
The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer’s disease: a positron emission tomography study in rats
.
Sci Rep
.
2019
;
9
:
14102
. .
49.
Fabbri
E
,
An
Y
,
Zoli
M
,
Simonsick
EM
,
Guralnik
JM
,
Bandinelli
S
,
Aging and the burden of multimorbidity: associations with inflammatory and anabolic hormonal biomarkers
.
J Gerontol A Biol Sci Med Sci
.
2015
;
70
:
63
70
. .
50.
Fabbri
E
,
Zoli
M
,
Gonzalez-Freire
M
,
Salive
ME
,
Studenski
SA
,
Ferrucci
L
.
Aging and multimorbidity: new tasks, priorities, and frontiers for integrated gerontological and clinical research
.
J Am Med Dir Assoc
.
2015
;
16
:
640
7
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.